TACE Plus Lenvatinib Versus TACE Plus Sorafenib for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Prospective Cohort Study

BACKGROUND AND OBJECTIVES: This study aimed to compare the efficacy of transarterial chemoembolization (TACE) plus sorafenib (TACE-S) to TACE plus lenvatinib (TACE-L) for the treatment of HCC with portal vein tumor thrombus (PVTT). METHODS: This cohort study recruited patients from September 2017 to...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Biao, Jie, Luo, Yang, Ting, Chen, Mingyang, Gao, Yuemei, Zhang, Tian, Zhang, Yuzu, Wu, Hao, Liao, Zhengyin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733478/
https://www.ncbi.nlm.nih.gov/pubmed/35004336
http://dx.doi.org/10.3389/fonc.2021.821599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733478/
https://www.ncbi.nlm.nih.gov/pubmed/35004336
http://dx.doi.org/10.3389/fonc.2021.821599

Ejemplares similares